Immunocore Holdings (IMCR) Interest Expenses (2023 - 2026)

Immunocore Holdings has disclosed Interest Expenses across 4 years of filings, most recently posting $3.1 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $3.1 million, up 0.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 million (down 34.56% YoY), and the FY2025 annual result was $12.2 million, down 35.44% from the prior year.
• Interest Expenses came in at $3.1 million for Q1 2026 at Immunocore Holdings, roughly flat from $3.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $7.0 million in Q4 2024 to a low of $1.2 million in Q1 2023.
• The 4-year median for Interest Expenses is $3.0 million (2025), against an average of $3.0 million.
• Across the five-year window, Interest Expenses soared 437.66% in 2024 and tumbled 56.62% in 2025, its largest moves.
• Immunocore Holdings' Interest Expenses stood at $1.3 million in 2023, then jumped by 437.66% to $7.0 million in 2024, then sank by 56.62% to $3.1 million in 2025, then retreated by 0.07% to $3.1 million in 2026.
• The last three Interest Expenses figures came in at $3.1 million (Q1 2026), $3.1 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.